Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin and Ifosfamide in Metastatic Sarcomatoid Kidney Cancer
NCT00003683Phase 2Completed
- Sponsor
- Unicancer
- Start
- Mar 1998
- Primary completion
- Nov 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, ifosfamide in sarcomatoid renal cell carcinoma (sRCC), sponsored by Unicancer. Started Mar 1998; status: completed.
02
Drugs
doxorubicinifosfamide
03
Conditions
sarcomatoid renal cell carcinoma (sRCC)
Beyond the preview
Go deeper on NCT00003683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003683.